What is the recommended treatment for a patient with abdominal ascariasis and worms in vomit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Abdominal Ascariasis with Worms in Vomit

For patients with abdominal ascariasis and worms in vomit, a single dose of albendazole 400 mg orally is the recommended first-line treatment. 1

Diagnosis Confirmation

The presence of worms in vomit provides direct visual confirmation of ascariasis infection. Additional diagnostic steps may include:

  • Concentrated stool microscopy or fecal PCR to confirm the diagnosis 1
  • Multiple stool samples (2-3) to increase diagnostic sensitivity 2
  • Examination for other clinical manifestations:
    • Abdominal pain (present in 80.12% of cases) 3
    • Palpable worm bolus (present in 46.47% of cases) 3

Treatment Algorithm

First-line Treatment:

  • Albendazole 400 mg orally as a single dose 1, 2

Alternative Treatment Options:

  • Mebendazole 500 mg orally as a single dose 1
  • Ivermectin 200 μg/kg orally as a single dose 1

For Severe Cases or Complications:

  • If intestinal obstruction is present:
    • Initial conservative management with IV fluids, nasogastric decompression, and antispasmodics 3
    • Surgical intervention if conservative management fails:
      • Enterotomy and evacuation of worms
      • Laparotomy with milking of worms into colon
      • Resection anastomosis in cases of bowel necrosis or perforation 3, 4

Follow-up and Monitoring

  • Clinical follow-up in 2-4 weeks 2
  • Consider a second dose of anthelmintic medication at follow-up visit 3
  • For persistent symptoms or suspected treatment failure:
    • Repeat stool examination
    • Consider alternative treatment 2

Prevention of Reinfection

  • Frequent handwashing with soap, especially before eating and after using the toilet 2
  • Daily changing of underwear and keeping fingernails short and clean 2
  • Environmental cleaning measures including washing bed linens in hot water 2
  • Treatment of all household members simultaneously 2

Treatment Efficacy and Considerations

  • Albendazole has a 98% cure rate for Ascaris lumbricoides infections 5, 6
  • A single dose of albendazole is ovicidal against Ascaris eggs, preventing further transmission 7
  • In endemic areas, consider repeated dosing (three doses at 6-week intervals) for complete eradication 6

Potential Pitfalls

  • Inadequate diagnosis or incomplete treatment may lead to recurrent infections 2
  • Emerging resistance has been documented in some helminth species, highlighting the need for proper dosing and follow-up 2
  • For prolonged treatment courses (>14 days), monitor for potential hepatotoxicity and leukopenia 2
  • Failure to treat all household members may result in reinfection 2

Special Populations

  • Children ≥2 years should receive the same dose as adults (albendazole 400 mg) 2
  • For pregnant women, treatment should be deferred until after the first trimester unless benefits outweigh risks 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Intestinal Worm Infections Treatment Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ascariasis causing small bowel obstruction in an adult female: A case report.

International journal of surgery case reports, 2023

Research

Albendazole in the treatment of intestinal helminthiasis in children.

Current medical research and opinion, 1985

Research

Successful eradication of Ascaris lumbricoides and hookworm infection after three repeated doses of albendazole.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2000

Research

Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis.

Annals of tropical medicine and parasitology, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.